Characteristics of the included trials (n = 17). by Xiaojuan Yang (794374)

Subjects:

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Statistical details of data presented in Fig 17. by Piotr Popik (292215)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Cumulative incidence of any cardiovascular diseases in the BIO-cohort vs. the Non-BIO-cohort. by Teng-Li Lin (5559284)

Subjects:

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. by Yan She (8639796)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Table 1_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.docx by Yong Sun (406434)

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Detection of HD in non-human samples. by Philippe Ndzomo (17706039)

Data Sheet 2_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.pdf by Yong Sun (406434)

Data Sheet 1_Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer.zip by Yong Sun (406434)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

DDX5 and DDX17 are required for KSHV lytic reactivation. by Praneet Kaur Sandhu (21156149)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. by Lei Li (29537)

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)